Stephens Investment Management Group LLC Grows Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

Stephens Investment Management Group LLC boosted its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 15.6% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 803,801 shares of the company's stock after acquiring an additional 108,190 shares during the quarter. Stephens Investment Management Group LLC owned 1.76% of Azenta worth $27,844,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. KLP Kapitalforvaltning AS bought a new position in Azenta in the 4th quarter valued at about $530,000. Deutsche Bank AG lifted its position in Azenta by 28.5% in the 4th quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock valued at $210,000 after acquiring an additional 931 shares in the last quarter. Thrivent Financial for Lutherans lifted its position in Azenta by 206.5% in the 4th quarter. Thrivent Financial for Lutherans now owns 35,223 shares of the company's stock valued at $1,761,000 after acquiring an additional 23,731 shares in the last quarter. SG Americas Securities LLC lifted its position in Azenta by 90.6% in the 1st quarter. SG Americas Securities LLC now owns 30,972 shares of the company's stock valued at $1,073,000 after acquiring an additional 14,719 shares in the last quarter. Finally, Corient Private Wealth LLC lifted its position in Azenta by 12.7% in the 4th quarter. Corient Private Wealth LLC now owns 28,505 shares of the company's stock valued at $1,425,000 after acquiring an additional 3,221 shares in the last quarter. Institutional investors own 99.08% of the company's stock.

Azenta Stock Performance

NASDAQ:AZTA traded down $0.68 on Friday, hitting $33.47. The stock had a trading volume of 459,941 shares, compared to its average volume of 738,662. The stock has a market cap of $1.53 billion, a P/E ratio of -24.08 and a beta of 1.64. Azenta, Inc. has a 1 year low of $23.91 and a 1 year high of $63.58. The firm's fifty day simple moving average is $29.19 and its two-hundred day simple moving average is $37.09.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 10.31% and a positive return on equity of 1.30%. During the same quarter in the previous year, the business posted $0.06 earnings per share. The business's revenue for the quarter was up 5.1% on a year-over-year basis. Equities research analysts predict that Azenta, Inc. will post 0.53 EPS for the current year.

Analysts Set New Price Targets

Several research firms have commented on AZTA. Evercore ISI increased their price objective on shares of Azenta from $29.00 to $35.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Needham & Company LLC decreased their price objective on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.